Yahoo Web Search

Search results

1. Avalo Therapeutics, Inc.

   NasdaqCM: AVTX

   13.10

   Add to watchlist

   Sign in to add to watchlist

   Sign In

   +1.95 (+17.49%)

   At close: Fri. May 24, 2024 4:00 PM EDT · Nasdaq Real Time Price (USD) · Market closed

   Full chart

   • 1D
   • 5D
   • 1M
   • 6M
   • YTD
   • 1Y
   • MAX

   • Open	10.98
     High	13.23
     Low	10.98

   • Mkt Cap	13.55M
     P/E (TTM)	N/A
     Div & Yield	N/A & N/A

   • Prev. Close	11.15
     52 Wk. Low	3.95
     52 Wk. High	1,130.40

   More about AVTX

   Related stocks

   • TPST
     Tempest Therapeutics, Inc.
     TPST
     3.2450
     +1.09%
   • ZVSA
     ZyVersa Therapeutics, Inc.
     ZVSA
     4.3100
     +1.41%
   • NVOS
     Novo Integrated Sciences, Inc.
     NVOS
     0.5025
     +7.14%
   • LIFW
     MSP Recovery, Inc.
     LIFW
     0.6992
     -0.94%
   • FEMY
     Femasys Inc.
     FEMY
     1.2800
     +3.23%

   More on Yahoo Finance

2. People also ask

   Should you buy Avalo Therapeutics (avtx) stock?

   • Avalo Therapeutics, Inc. is currently sporting a Zacks Rank of #2 (Buy). The Zacks Consensus Estimate for AVTX's full-year earnings has moved 94.5% higher within the past quarter. This means that analyst sentiment is stronger and the stock's earnings outlook is improving.

   Is Avalo Therapeutics (AVTX) Stock Outpacing Its Medical Peers This Yea…

   finance.yahoo.com/news/avalo-therapeutics-avtx-stock-outpacing-134009791.html

   See all results for this question

   Is Annexon (avtx) a good stock to buy?

   • Stocks in this group have lost about 6.9% so far this year, so AVTX is performing better this group in terms of year-to-date returns. On the other hand, Annexon, Inc. belongs to the Medical - Biomedical and Genetics industry. This 506-stock industry is currently ranked #86. The industry has moved -3.4% year to date.

   Is Avalo Therapeutics (AVTX) Stock Outpacing Its Medical Peers This Yea…

   finance.yahoo.com/news/avalo-therapeutics-avtx-stock-outpacing-134009791.html

   See all results for this question

   Is Avalo Therapeutics (Avalo) outperforming the medical sector this year?

   • This means that Avalo Therapeutics, Inc. is outperforming the sector as a whole this year. One other Medical stock that has outperformed the sector so far this year is Annexon, Inc. (ANNX). The stock is up 5.7% year-to-date. Over the past three months, Annexon, Inc.'s consensus EPS estimate for the current year has increased 42.7%.

   Is Avalo Therapeutics (AVTX) Stock Outpacing Its Medical Peers This Yea…

   finance.yahoo.com/news/avalo-therapeutics-avtx-stock-outpacing-134009791.html

   See all results for this question

3. • • Avalo Therapeutics (NASDAQ: AVTX) just reported results for the fourth quarter of 2023. Avalo Therapeutics reported earnings per share of -$10.12. This was below the analyst estimate for EPS of -$4.80. The company reported revenue of $571,000. This was 90.33% better than the analyst estimate for revenue of $300,000.
     Reference:

     AVTX Stock Earnings: Avalo Therapeutics Misses EPS, Beats ...

4. seekingalpha.com › symbol › AVTXAvalo Therapeutics, Inc. (AVTX) Stock Price, Quote, News ...

   seekingalpha.com › symbol › AVTX

   • Cached

   5 days ago · A high-level overview of Avalo Therapeutics, Inc. (AVTX) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.

   • Ratings

     Ratings - Avalo Therapeutics, Inc. (AVTX) Stock Price,...

   • Financials

     Financials - Avalo Therapeutics, Inc. (AVTX) Stock Price,...

   • Dividends

     Dividends - Avalo Therapeutics, Inc. (AVTX) Stock Price,...

   • Valuation

     Valuation - Avalo Therapeutics, Inc. (AVTX) Stock Price,...

   • Profitability

     Profitability - Avalo Therapeutics, Inc. (AVTX) Stock Price,...

   • Momentum

     Momentum - Avalo Therapeutics, Inc. (AVTX) Stock Price,...

   • Peers

     Peers - Avalo Therapeutics, Inc. (AVTX) Stock Price, Quote,...

   • Options

     Get Options quotes for Avalo Therapeutics, Inc. (AVTX)....

5. www.marketbeat.com › stocks › NASDAQAvalo Therapeutics (AVTX) Stock Price, News & Analysis

   www.marketbeat.com › stocks › NASDAQ

   • Cached

   5 days ago · Should You Buy or Sell Avalo Therapeutics Stock? Get The Latest AVTX Stock Analysis, Price Target, Headlines, and Short Interest at MarketBeat.

   • Location: 540 Gaither Rd Ste 400, Rockville, Maryland 20850-6713
   • Email: ir@cerecor.com

   • Phone: (410) 522-8707
   • Employees: 19

6. markets.businessinsider.com › news › stocksAVTX Stock Earnings: Avalo Therapeutics Misses EPS, Beats ...

   markets.businessinsider.com › news › stocks

   • Cached

   3 days ago · InvestorPlace. May. 24, 2024, 11:52 AM. InvestorPlace - Stock Market News, Stock Advice & Trading Tips. Avalo Therapeutics (NASDAQ: AVTX) just reported results for the fourth quarter of 2023 ...

7. Videos

   • 

     1:18

     youtube.com

     AVTX Stock (Avalo Therapeutics) AVTX STOCK PREDICTIONS! AVTX STOCK Analysis AVTX stock news today

     Mar 31, 2024

     1 Views

   • 

     1:09

     youtube.com

     AVTX STOCK MONDAY APRIL NEXT! (buying??) avtx stock

     Mar 31, 2024

     1 Views

   • 

     3:08

     youtube.com

     AVTX Stock - Avalo Therapeutics Inc Stock Breaking News Today | AVTX Stock Price Prediction | AVTX

     Apr 1, 2024

   View all

8. finance.yahoo.com › news › avalo-therapeutics-avtxIs Avalo Therapeutics (AVTX) Stock Outpacing Its Medical ...

   finance.yahoo.com › news › avalo-therapeutics-avtx

   • Cached

   5 days ago · Has Avalo Therapeutics, Inc. (AVTX) been one of those stocks this year? By taking a look at the stock's year-to-date performance in comparison to its Medical peers, we might be able to answer...

9. marketwirenews.com › news-releases › avtx-stockAVTX - AVTX Stock Earnings: Avalo Therapeutics Misses EPS...

   marketwirenews.com › news-releases › avtx-stock

   • Cached

   2 days ago · InvestorPlace - Stock market News, Stock Advice & Trading Tips . Avalo Therapeutics (NASDAQ: AVTX ) just reported results for the fourth quarter of 2023. Avalo Therapeutics reported earnings per share of -$10.12. This was below the analyst estimate for EPS of -$4.80. The company reported revenue of $571,000.

10. stockanalysis.com › stocks › avtxAvalo Therapeutics, Inc. (AVTX) Stock Price, Quote & News ...

    stockanalysis.com › stocks › avtx

    • Cached

    5 days ago · Get a real-time Avalo Therapeutics, Inc. (AVTX) stock price quote with breaking news, financials, statistics, charts and more.

11. www.morningstar.com › stocks › xnasAVTX Stock Price Quote | Morningstar

    www.morningstar.com › stocks › xnas

    • Cached

    4 days ago · See the latest Avalo Therapeutics Inc stock price (AVTX:XNAS), related news, valuation, dividends and more to help you make your investing decisions.